Heidi Cuthbert

Coinbase and Robinhood are increasingly being valued on future product expansion, with prediction markets emerging as a central growth driver despite expected weak first-quarter trading results.

Bitget has launched a new platform called IPO Prime, allowing users to gain tokenised exposure to private companies before they go public, starting with a product linked to SpaceX.

New Zealand energy firm Mercury NZ (ASX:MCY) has raised its earnings guidance for the 2026 financial year.

Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved IDVYNSO™, a new single-tablet antiretroviral regimen.

3M Company (NYSE:MMM) delivered a solid start to 2026, reporting adjusted earnings that exceeded Wall Street expectations and reaffirming its financial outlook for the year.

Youxin Technology (NASDAQ:YAAS) has announced the release of audited financial statements for Celnet for the fiscal years ended September 30, 2025, and 2024.

Invion (ASX:IVX) announced the expansion of its clinical trial for INV043, moving into the final stage of its current non-melanoma skin cancer study.

Lynas Rare Earths (ASX:LYC) logged record revenue of $265 million for the March quarter, a 115% increase over the previous period.

MA Financial Group (ASX:MAF) reported a 44% year-on-year increase in assets under management, reaching $14.8 billion as of March 31.

Atlas Arteria (ASX:ALX) announced a 0.1% increase in proportionate toll revenue for the three months ended March 31.